TickerFacts.

Company research / GMED

Globus Medical Inc (GMED)

Build a valuation ↗↓ Download CSV

SEC name GLOBUS MEDICAL INC · CIK 0001237831 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Globus Medical Inc reported revenue of $2.94B. Revenue grew 16.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $3.14B.

Key ratios (year ended 2025-12-31)

67.4%
Gross margin (computed)
16.3%
Operating margin
18.3%
Net margin
11.8%
Return on year-end equity
16.7%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-16

Headquarters locality: Audubon · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312020-09-302020-06-302020-03-312019-12-31
Revenue$3.14B$2.94B$2.52B$1.57B$1.02B$958.10M$789.04Mn/an/an/a$785.37M
Cost of Revenue$989.14M$957.80M$1.04B$548.17M$263.73M$239.22M$217.46Mn/an/an/a$179.97M
Gross Profit$2.16B$1.98B$1.48B$1.02B$759.12M$718.88M$571.58Mn/an/an/a$605.39M
R&D Expense$147.06M$147.25M$163.75M$124.01M$73.02M$97.35M$84.52Mn/an/an/a$60.07M
Operating Income$639.52M$479.82M$165.99M$133.14M$227.95M$171.95M$111.43Mn/an/an/a$171.99M
Depreciation & Amortizationn/a$276.84M$253.39M$145.53M$68.25M$69.87M$62.87Mn/an/an/a$52.73M
EBITDAn/a$756.66M$419.38M$278.67M$296.20M$241.82M$174.31Mn/an/an/a$224.72M
Net Income$535.43M$537.87M$102.98M$122.87M$190.17M$149.19M$102.28Mn/an/an/a$155.21M
EPS (Diluted)n/a$3.92$0.75$1.07$1.85$1.44$1.01n/an/an/a$1.52
Total Assets$5.49B$5.30B$5.25B$5.09B$2.08B$1.96B$1.68Bn/an/an/a$1.53B
Total Liabilities$719.65M$729.51M$1.07B$1.09B$229.75M$215.88M$173.19Mn/an/an/a$129.62M
Shareholders' Equity$4.77B$4.57B$4.18B$4.00B$1.85B$1.74B$1.51B$1.42B$1.34B$1.36B$1.40B
Cash & Equivalents$507.75M$526.16M$784.44Mn/an/an/an/an/an/an/a$195.47M
Operating Cash Flow$910.39M$753.45M$520.64M$243.50M$178.47M$276.27M$198.79Mn/an/an/a$171.97M
Capital Expenditures$154.80M$164.68M$115.43M$78.27M$74.05M$56.90M$63.66Mn/an/an/a$70.75M
Free Cash Flow$755.59M$588.77M$405.21M$165.22M$104.42M$219.38M$135.13Mn/an/an/a$101.22M
Share Repurchases$221.06M$300.45M$85.79M$225.56M$144.49Mn/a$104.67Mn/an/an/an/a
Shares Outstandingn/an/an/an/an/an/an/an/an/an/a99.83M
Weighted Average Diluted Sharesn/a137.06M137.86M114.63M102.64M103.62M100.97Mn/an/an/a102.00M
EPS (Basic)n/a$3.98$0.76$1.09$1.89$1.48$1.04n/an/an/a$1.57

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView